Iguana Healthcare Management’s ADMA Biologics ADMA Stock Holding History

Iguana Healthcare Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.76M	Hold	600,000	–	–	1.82%	21
2017 Q4	$1.93M	Buy	600,000 +35,000	+6%	+$97.9K	1.25%	30
2017 Q3	$1.74M	Buy	565,000 +415,000	+277%	+$1.38M	0.95%	38
2017 Q2	$555K	Buy	150,000 +50,000	+50%	+$201K	0.31%	56
2017 Q1	$488K	Hold	100,000	–	–	0.24%	66
2016 Q4	$512K	Sell	100,000 -200,000	-67%	-$1.15M	0.31%	57
2016 Q3	$2.17M	Buy	300,000 +175,000	+140%	+$1.11M	0.39%	66
2016 Q2	$744K	Buy	+125,000	New	+$875K	0.3%	68

Other funds holding ADMA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

MWVC

Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Iguana Healthcare Management's ADMA Position: Q1 2018 in Review

Iguana Healthcare Management held its ADMA Biologics (ADMA) position steady in Q1 2018 at 600,000 shares worth $2.76M. The position accounts for 1.82% of the portfolio, ranked #21.

Iguana Healthcare Management first reported a position in ADMA in Q2 2016 and has held it in 8 quarters since. 34 funds tracked by Wall St. Rank hold ADMA as of Q1 2018.

Iguana Healthcare Management held 600,000 shares of ADMA Biologics worth $2.76M as of Q1 2018.
Iguana Healthcare Management left its ADMA Biologics share count unchanged in Q1 2018.
ADMA Biologics made up 1.82% of Iguana Healthcare Management's portfolio in Q1 2018, its #21 holding.
Iguana Healthcare Management first reported a position in ADMA Biologics in Q2 2016 and has held it in 8 quarters since.
34 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.